Chronic Pain and Erectile Dysfunction: Mechanism, Treatment, and Future Perspective
Main Article Content
Abstract
Erectile dysfunction is a problem with multiple causes and is challenging to diagnose. Chronic pain has been associated with erectile dysfunction in some studies. Chronic pain can be a potential direct or indirect cause of sexual dysfunction. A decreased sexual desire due to restricted sexual activity in chronic pain can result in erectile dysfunction. Erectile dysfunction has been linked to migraines, chronic pain, and psychological factors. Multiple neurotransmitters may contribute to the pathophysiology of erectile dysfunction. Depression and anxiety, as well as painkillers like pregabalin and opioids, can be indirect causes of erectile dysfunction. Numerous factors affect the occurrence of erectile dysfunction; therefore, erectile dysfunction must be treated holistically.
Downloads
Article Details
References
Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, et al. Erectile dysfunction. Nat Rev Dis Prim. 2016;2:16003. doi: 10.1038/ nrdp.2016.3.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61. doi: 10.1016/S0022-5347(17)34871-1.
Neijenhuijs KI, Holtmaat K, Aaronson NK, Holzner B, Terwee CB, Cuijpers P, et al. The International Index of Erectile Function (IIEF)—A Systematic Review of Measurement Properties. J Sex Med. 2019;16(7):1078–91. doi: 10.1016/j. jsxm.2019.04.010.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-30. doi: 10.1016/s0090- 4295(97)00238-0
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med. 2015;162(4):276–86. doi: 10.7326/ M14-2559.
Arabkheradmand J, Foroutan SK, Ranjbar S, Abbasi T, Hessami S, Gorji A. Improvement of chronic pain by treatment of erectile dysfunction. J Sex Med. 2008;5(12):2911–6. doi: 10.1111/j.1743- 6109.2008.01006.x.
Mccabe MP, Althof SE. A systematic review of the psychosocial outcomes associated with erectile dysfunction: Does the impact of erectile dysfunction extend beyond a man’s inability to have sex? J Sex Med. 2014;11(2):347–63. doi: 10.1111/jsm.12374.
Martins I, Carvalho P, de Vries MG, Teixeira- Pinto A, Wilson SP, Westerink BHC, et al. Increased noradrenergic neurotransmission to a pain facilitatory area of the brain is implicated in facilitation of chronic pain. Anesthesiology. 2015;123(3):642–53. doi: 10.1097/ ALN.0000000000000749.
Melis MR, Argiolas A. Central control of penile erection: A re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats. Neurosci Biobehav Rev. 2011;35(3):939–
doi: 10.1016/j.neubiorev.2010.10.014.
Simonsen U, Comerma-Steffensen S, Andersson KE. Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction. Basic Clin Pharmacol Toxicol. 2016;119:63–74. doi: 10.1111/bcpt.12653.
Giuliano F. Neurophysiology of Erection and Ejaculation. J Sex Med. 2011;8(SUPPL. 4):310–5. doi: 10.1111/j.1743-6109.2011.02450.x.
Putnam SK, Du J, Sato S, Hull EM. Testosterone restoration of copulatory behavior correlates with medial preoptic dopamine release in castrated male rats. Horm Behav. 2001;39(3):216–24. doi: 10.1006/hbeh.2001.1648.
Cellek S. Nitrergic-noradrenergic interaction in penile erection: A new insight into erectile dysfunction. Drugs of Today. 2000;36(2–3):135–
doi: 10.1358/dot.2000.36.2-3.568787.
Schjørring O, Kun A, Flyvbjerg A, Kirkeby HJ, Jensen JB, Simonsen U. Flow-Evoked Vasodilation Is Blunted in Penile Arteries from Zucker Diabetic Fatty Rats. J Sex Med. 2012;9(7):1789–800. doi: 10.1111/j.1743-6109.2012.02743.x.
Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Ment Heal Clin. 2016;6(4):191–6. doi: 10.9740/ mhc.2016.07.191.
Wu LJ, Kim SS, Li X, Zhang F, Zhuo M. Sexual attraction enhances glutamate transmission in mammalian anterior cingulate cortex. Mol Brain. 2009;2(1). doi: 10.1186/1756-6606-2-9.
Al-Hassany L, Vries T de, Carpay JA, MaassenVanDenBrink A. Could erectile dysfunction be a side effect of CGRP inhibition? A case report. Cephalalgia. 2022;42(3):257–61. doi: 10.1177/03331024211037304.
Fernandez F, Colson N, Quinlan S, MacMillan J, Lea RA, Griffiths LR. Association between migraine and a functional polymorphism at the dopamine β-hydroxylase locus. Neurogenetics. 2009;10(3):199–208. doi: 10.1007/s10048-009-
-2.
Aksoy D, Solmaz V, Cevik B, Gencten Y, Erdemir F, Kurt SG. The evaluation of sexual dysfunction in male patients with migraine and tension type headache. J Headache Pain. 2013;14(1). doi: 10.1186/1129-2377-14-46.
Huang CY, Keller JJ, Sheu JJ, Lin HC. Migraine and erectile dysfunction: Evidence from a population-based case-control study. Cephalalgia. 2012;32(5):366–72. doi: 10.1177/0333102412439801.
Nemichandra SC, Pradeep R, Harsha S, Radhika K, Iqbal R. Erectile dysfunction in migraine in Indian patients. Ann Indian Acad Neurol. 2020;23(6):792–
doi: 10.4103/aian.AIAN_554_19.
Deyo RA, Smith DHM, Johnson ES, Tillotson CJ, Donovan M, Yang X, et al. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Phila Pa 1976). 2013;38(11):909–15. doi: 10.1097/ BRS.0b013e3182830482.
Bozkurt M, Gocmez C, Soylemez H, Daggulli M, Em S, Yildiz M, et al. Association between neuropathic pain, pregabalin treatment, and erectile dysfunction. J Sex Med. 2014;11(7):1816–
doi: 10.1111/jsm.12458.
Wu SH, Chuang E, Chuang TY, Lin CL, Lin MC, Yen DJ, et al. A nationwide population-based cohort study of migraine and organic-psychogenic erectile dysfunction. Med (United States). 2016;95(10). doi: 10.1097/MD.0000000000003065.
Ajo R, Inda M del M, Mateu M, Segura A, Ballester P, Muriel J, et al. Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study. Int J Impot Res. 2021;33(3):339–47. doi: 10.1038/ s41443-020-0294-9.
Akerman S, Goadsby PJ. Dopamine and migraine: Biology and clinical implications. Cephalalgia. 2007;27(11):1308–14. doi: 10.1111/j.1468-2982.2007.01478.x.
Hashizume M, Yamada U, Sato A, Hayashi K, Amano Y, Makino M, et al. Stress and psychological factors before a migraine attack: A time-based analysis. Biopsychosoc Med. 2008;2. doi: 10.1186/1751-0759-2-14.
Gruenwald I. Sexual Dysfunction in Patients with Chronic Pain. Urol Nephrol Open Access J. 2017;4(6). doi: 10.15406/unoaj.2017.04.00147.
Liu Q, Zhang Y, Wang J, Li S, Cheng Y, Guo J, et al. Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis. J Sex Med. 2018;15(8):1073–82. doi: 10.1016/j. jsxm.2018.05.016.
Argiolas A, Melis MR. Neuropeptides and central control of sexual behaviour from the past to the present: A review. Prog Neurobiol. 2013;108:80–
doi: 10.1016/j.pneurobio.2013.06.006.
Bivalacqua TJ, Champion HC, Abdel-Mageed AB, Kadowitz PJ, Hellstrom WJG. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod. 2001;65(5):1371–7. doi: 10.1095/
biolreprod65.5.1371.
Fraser LA, Morrison D, Morley-Forster P, Paul TL, Tokmakejian S, Nicholson RL, et al. Oral opioids for chronic non-cancer pain: Higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes. 2009;117(1):38–43. doi: 10.1055/s-2008-1076715.
Rajkumar RP, Kumaran AK. Depression and anxiety in men with sexual dysfunction: A retrospective study. Compr Psychiatry. 2015;60:114–8. doi: 10.1016/j.comppsych.2015.03.001.
Ye N, Huang Y, Zhao H, Li G. Association between the serotonin transporter linked polymorphic region and lifelong premature ejaculation: An updated meta-analysis of case-control studies. Medicine (Baltimore). 2020;99(41):e22169. doi: 10.1097/MD.0000000000022169.
Zhang Y, Zheng T, Tu X, Chen X, Wang Z, Chen S, et al. Erectile dysfunction in chronic prostatitis/ chronic pelvic pain syndrome: Outcomes from a multi-center study and risk factor analysis in a single center. PLoS One. 2016;11(4). doi: 10.1371/ journal.pone.0153054.
Ja HK, Soo WK, Paick JS. Quality of life and psychological factors in chronic prostatitis/chronic pelvic pain syndrome. Urology. 2005;66(4):693– 701. doi: 10.1016/j.urology.2005.04.050.
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.
Kwan KSH, Roberts LJ, Swalm DM. Sexual dysfunction and chronic pain: The role of psychological variables and impact on quality of life. Eur J Pain. 2005;9(6):643. doi: 10.1016/j. ejpain.2004.12.008.
Safarinejad MR. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: A double- blind placebo-controlled and randomized study. BJU Int. 2010;106(6):840–7. doi: 10.1111/j.1464- 410X.2009.09154.x.
Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT. Sexual functioning in patients with recurrent major depressive disorder enrolled in the prevent study. J Nerv Ment Dis. 2013;201(4):266–73. doi: 10.1097/ NMD.0b013e318288d298.
Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo- controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor- induced sexual dysfunction. J Clin Psychiatry. 2004;65(1):62–7. doi: 10.4088/JCP.v65n0110.
Clayton AH, Gommoll C, Chen D, Nunez R, Mathews
M. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: Results from a phase IV clinical trial. Int Clin Psychopharmacol. 2015;30(4):216–23. doi: 10.1097/YIC.0000000000000075.
Jacobsen PL, Mahableshwarkar AR, Palo WA, Chen Y, Dragheim M, Clayton AH. Treatment- emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: A pooled analysis. CNS Spectr. 2016;21(5):367–78. doi: 10.1017/ S1092852915000553.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013;2013(5). doi: 10.1002/14651858. CD003382.pub3.
Shridharani AN, Brant WO. The treatment of erectile dysfunction in patients with neurogenic disease. Transl Androl Urol. 2016;5(1):88–101. doi: 10.3978/j.issn.2223-4683.2016.01.07.
Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G. Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 Inhibitors. Review of the Literature. J Sex Med. 2012;9(4):970–85. doi: 10.1111/j.1743-6109.2011.02615.x.
Modabbernia A, Sohrabi H, Nasehi AA, Raisi F, Saroukhani S, Jamshidi A, et al. Effect of saffron on fluoxetine-induced sexual impairment in men: Randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2012;223(4):381–8. doi: 10.1007/s00213-012-2729-6.
Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, et al. Antidepressant properties of bioactive fractions from the extract of crocus sativus L. J Nat Med. 2010;64(1):24–30. doi: 10.1007/s11418- 009-0360-6.
Baskerville TA, Douglas AJ. Interactions between dopamine and oxytocin in the control of sexual behaviour. Prog Brain Res. 2008;170:277–90. doi: 10.1016/S0079-6123(08)00423-8.
Dinsmore WW, Wyllie MG. Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction. BJU Int. 2008;102(8):933–7. doi: 10.1111/j.1464-410X.2008.07764.x.
Mcmahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol. 1999;162(6):1992–8. doi: 10.1016/S0022-
(05)68085-8.
McMahon CG. Current diagnosis and management of erectile dysfunction. Med J Aust. 2019;210(10):469–76. doi: 10.5694/mja2.50167.
Lai B yong, Cao H juan, Yang G yan, Jia L yan, Grant S, Fei Y tong, et al. Acupuncture for treatment of erectile dysfunction: A systematic review and meta-analysis. World J Men?s Heal. 2019;37(3):322–38. doi: 10.5534/wjmh.180090.
Yiou R, Hamidou L, Birebent B, Bitari D, Lecorvoisier P, Contremoulins I, et al. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. Eur Urol. 2016;69(6):988–91. doi: 10.1016/j.eururo.2015.09.026.
Butt JH, S Eddelien H, Kruuse C. The headache and aura-inducing effects of sildenafil in patients with migraine with aura. Cephalalgia. 2022;42(10):984–92. doi:10.1177/03331024221088998
Kim SC, Lee SW, Seo KK. Characteristics of pain following intracavernous injection of prostaglandin E1. J Korean Med Sci. 1997;12(4):327-331. doi:10.3346/jkms.1997.12.4.327